Published in J Biol Inorg Chem on September 01, 2015
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. Med Res Rev (2016) 0.80
N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes. Sci Rep (2016) 0.78
Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities. Int J Mol Sci (2016) 0.75
Progress of small molecular inhibitors in the development of anti-influenza virus agents. Theranostics (2017) 0.75
Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors. PLoS One (2017) 0.75
A short history of SHELX. Acta Crystallogr A (2007) 7339.18
New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr B (2002) 16.68
Development and validation of a genetic algorithm for flexible docking. J Mol Biol (1997) 14.36
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model (2011) 6.49
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis (2007) 5.21
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature (2009) 4.49
Global transmission of oseltamivir-resistant influenza. N Engl J Med (2009) 4.34
Iron and cancer: more ore to be mined. Nat Rev Cancer (2013) 2.40
Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol (2010) 2.31
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob Agents Chemother (1994) 2.13
Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis (2010) 2.03
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors. J Med Chem (2003) 1.87
Minimum molecular architectures for transcription and replication of the influenza virus. Proc Natl Acad Sci U S A (2002) 1.70
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob Agents Chemother (1996) 1.58
Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J Virol (2010) 1.42
Metal ion catalysis of RNA cleavage by the influenza virus endonuclease. Biochemistry (1999) 1.41
In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res (2006) 1.38
Nucleoside monophosphate complex structures of the endonuclease domain from the influenza virus polymerase PA subunit reveal the substrate binding site inside the catalytic center. J Virol (2009) 1.35
Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase. PLoS Pathog (2012) 1.34
Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease. PLoS Pathog (2012) 1.30
The molecular anatomy of influenza virus RNA polymerase. Biol Chem (1997) 1.29
Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9. Mol Pharmacol (2010) 1.21
Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161). Invest New Drugs (2007) 1.06
Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor. Chem Biol Drug Des (2010) 1.04
Emerging antiviral strategies to interfere with influenza virus entry. Med Res Rev (2013) 0.98
Influenza virus resistance to antiviral therapy. Adv Pharmacol (2013) 0.92
Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease. J Virol (2013) 0.91
3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease. ACS Med Chem Lett (2013) 0.91
Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis. Fitoterapia (2013) 0.91
Magnesium-dependent RNA binding to the PA endonuclease domain of the avian influenza polymerase. J Phys Chem B (2014) 0.88
Metal-chelating 2-hydroxyphenyl amide pharmacophore for inhibition of influenza virus endonuclease. Mol Pharm (2013) 0.87
Antiretroviral activity of thiosemicarbazone metal complexes. J Med Chem (2010) 0.86
Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate. Antiviral Res (2013) 0.86
An integrated biological approach to guide the development of metal-chelating inhibitors of influenza virus PA endonuclease. Mol Pharmacol (2014) 0.85
Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus. Antiviral Res (2012) 0.81
A versatile salicyl hydrazonic ligand and its metal complexes as antiviral agents. J Inorg Biochem (2015) 0.80
Synthesis, X-ray crystal structure, DNA binding, antioxidant and cytotoxicity studies of Ni(ii) and Pd(ii) thiosemicarbazone complexes. Metallomics (2011) 0.79
DNA, protein binding, cytotoxicity, cellular uptake and antibacterial activities of new palladium(II) complexes of thiosemicarbazone ligands: effects of substitution on biological activity. Metallomics (2011) 0.79
Isatin-β-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg Med Chem Lett (2011) 0.78
Synthesis and in vitro evaluation of palladium(II) salicylaldiminato thiosemicarbazone complexes against Trichomonas vaginalis. J Inorg Biochem (2011) 0.78
Exploring the influence of the protein environment on metal-binding pharmacophores. J Med Chem (2014) 0.76